- Home
- ALLR vs EVAX Comparison
ALLR vs EVAX Comparison
Compare ALLR & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- EVAX
- Stock Information
- Founded
- ALLR 2004
- EVAX 2008
- Country
- ALLR United States
- EVAX Denmark
- Employees
- ALLR N/A
- EVAX N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALLR Health Care
- EVAX Health Care
- Exchange
- ALLR Nasdaq
- EVAX Nasdaq
- Market Cap
- ALLR 15.8M
- EVAX 15.1M
- IPO Year
- ALLR N/A
- EVAX 2021
- Fundamental
- Price
- ALLR $0.94
- EVAX $3.24
- Analyst Decision
- ALLR Strong Buy
- EVAX Strong Buy
- Analyst Count
- ALLR 1
- EVAX 2
- Target Price
- ALLR $9.00
- EVAX $10.00
- AVG Volume (30 Days)
- ALLR 367.8K
- EVAX 95.0K
- Earning Date
- ALLR 08-15-2025
- EVAX 08-14-2025
- Dividend Yield
- ALLR N/A
- EVAX N/A
- EPS Growth
- ALLR N/A
- EVAX N/A
- EPS
- ALLR N/A
- EVAX N/A
- Revenue
- ALLR N/A
- EVAX $3,176,000.00
- Revenue This Year
- ALLR N/A
- EVAX N/A
- Revenue Next Year
- ALLR N/A
- EVAX N/A
- P/E Ratio
- ALLR N/A
- EVAX N/A
- Revenue Growth
- ALLR N/A
- EVAX 1042.45
- 52 Week Low
- ALLR $0.61
- EVAX $1.20
- 52 Week High
- ALLR $6.00
- EVAX $17.75
- Technical
- Relative Strength Index (RSI)
- ALLR 47.03
- EVAX 62.32
- Support Level
- ALLR $0.85
- EVAX $2.91
- Resistance Level
- ALLR $1.01
- EVAX $3.40
- Average True Range (ATR)
- ALLR 0.05
- EVAX 0.22
- MACD
- ALLR -0.01
- EVAX 0.02
- Stochastic Oscillator
- ALLR 47.55
- EVAX 79.11
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.